SVA SINOVAC BIOTECH LTD
Price Chart
Executive Summary
Sinovac reported flat revenue of $130.3M for H1 2025, but swung from a $93.9M profit to a $21.7M net loss, driven by $68.1M in IPR&D/goodwill impairments and reduced investment income. The company also restated prior-period financials and declared a $4.0B special dividend, masking underlying operational weakness.
Actionable Insight
The earnings collapse and restatement signal deteriorating fundamentals despite a high cash balance. Traders should watch for further guidance on the rabies vaccine launch and resolution of the 2018 PIPE share litigation, which could impact the dividend payable and share count.
Key Facts
- Revenue nearly flat at $130.3M (+1.2% YoY)
- Net loss attributable to common shareholders of $21.7M vs net income of $93.9M in H1 2024
- Impairment of $68.1M in IPR&D and goodwill related to rabies vaccine subsidiary
- Restatement of prior-period financial statements (Non-Reliance on previously issued numbers)
- Declared a special cash dividend of $55.00 per share totaling $4.0B, with $3.3B paid
Financial Impact
Earnings collapsed from $93.9M net income to $21.7M net loss; impairments totaled $68.1M; special dividend of $4.0B declared
Risk Factors
- Further impairments from delayed vaccine launches
- Litigation over 2018 PIPE shares may affect capital structure
- Restatement raises credibility concerns with investors
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-054027 |
| Document: ea0289810-6k_sinovac.htm | 0001213900-26-054027 |
| Document: 0001213900-26-054027-index-headers.html | 0001213900-26-054027 |
| Document: 0001213900-26-054027-index.html | 0001213900-26-054027 |
| Document: 0001213900-26-054027.txt | 0001213900-26-054027 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
4d ago
|
20-F
| $6.47 awaiting T+5 | awaiting T+5 | — | $6.47 (+0.00%) |
|
May 29, 2026
11d ago
|
6-K
| $6.47 $6.47 | · 0.00% | ▼ −2.75% | $6.47 (+0.00%) |
|
May 21, 2026
19d ago
|
6-K
| $6.47 $6.47 | · 0.00% | ▼ −1.85% | $6.47 (−0.00%) |
|
May 8, 2026
4w ago
|
6-K
| $6.47 $6.47 | · 0.00% | ▼ −0.09% | $6.47 (+0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access